Supplementary Figure 6 from Antibody–Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Effects of α5β1 integrin and its downstream signaling components on VM tube formation
Supplementary Figure 6 from Antibody–Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling | Synapse